期刊文献+

NLRP3炎症小体介导的炎症相关疾病研究进展 被引量:22

NLRP3 inflammasome and its role in inflammation-related diseases
原文传递
导出
摘要 炎症小体在炎症相关疾病的发生发展中发挥重要作用,其中NLRP3炎症小体能够被多种病原相关分子模式(pathogen-associated molecular patterns,PAMPs)和损伤相关分子模式(damage-associated molecular patterns,DAMPs)激活,进而活化caspase-1,释放成熟形式的IL-1β和IL-18,引起机体的炎症反应,并参与多种疾病的发生发展,包括2型糖尿病、痛风、动脉粥样硬化、神经退行性疾病、肿瘤、炎症性肠病等。因此,研究NLRP3炎症小体的作用机制不仅有助于加深对炎症性疾病发生发展的认识,也为寻找此类疾病的潜在治疗靶点提供了新的思路。就NLRP3炎症小体在炎症相关疾病中的研究进展作一综述。 Inflammasomes play an important role in the initial and progressive process among various inflammation-related diseases.The NLRP3 inflammasome is vital in the innate immune system.It could recognize series of pathogen-associated molecular patterns(PAMPs) and damage-associated molecular patterns(DAMPs) and be activated.Activated NLRP3 inflammasome stimulates caspase-1 activation that triggers maturation and secretion of pro-inflammatory cytokines,including interleukin-1β and interleukin-18.A number of recent landmark studies revealed that inflammation-related diseases such as type 2 diabetes,gout,atherosclerosis,neurodegenerative diseases,cancer,inflammatory bowel disease(IBD) are closely related with NLRP3 inflammasome.Thus,study on the NLRP3 inflammasome in inflammation-related diseases not only expands our understanding on these diseases,but also provides a potential therapeutic target for these diseases.Here we review the recent studies on the pathological contributions of NLRP3 inflammasome in various inflammation-related diseases.
作者 蒋丹露 刘阳阳 孙如愚 陈晟 王迪 JIANG Dan-Lu LIU Yang-Yang SUN Ru-Yu CHEN Sheng WAND Di(Research Group of Immune Metabolism, Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058, China)
出处 《生命科学》 CSCD 2017年第9期898-907,共10页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金项目(31670926) 国家自然科学基金优秀青年基金项目(31522020)
关键词 NLRP3炎症小体 炎症相关疾病 IL-1Β IL-18 NLRP3 inflammasome inflammation-related disease IL-1β IL-18
  • 相关文献

参考文献1

二级参考文献24

  • 1Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med2005; 143: 499-516. 被引量:1
  • 2Burns CM, Wortmann RL. Gout therapeutics: new drugs for an old disease. Lancet2011; 377: 165-177. 被引量:1
  • 3Martinon F. Signaling by ROS drives inflammasome activation. EurJ Imrnunol2010; 40: 616-619. 被引量:1
  • 4Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin- interacting protein links oxidative stress to inflammasome activation. Nat Immunol2010; 11: 136-140. 被引量:1
  • 5Rubartelli A, Gattorno M, Netea MG, Dinarello CA. Interplay between redox status and inflammasome activation. Trends Immunel 2011; 32: 559-566. 被引量:1
  • 6Tschopp J, Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunel 2010; 10: 210-215. 被引量:1
  • 7Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inftammasome activation. Nature 2011; 469:221-225. 被引量:1
  • 8Cruz CM, Rinna A, Forman H J, Ventura AL, Persechini PM, Ojcius DM. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 2007; 282: 2871-2879. 被引量:1
  • 9Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008: 320: 674-677. 被引量:1
  • 10Wakabayashi N, Slocum SL, Skoko J J, Shin S, Kensler TW. When NRF2 talks, who's listening? Antioxid Redox Signal 2010: 13: 1649-1663. 被引量:1

共引文献14

同被引文献202

引证文献22

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部